Ultragenyx Pharmaceutical Inc (RARE)

106.65 +0.25  +0.23% NASDAQ May 13, 16:59 USD
View Full Chart
Price Chart
View All RARE News

News

View All Events

Events

Date Type Description
07/30/2021 00:00 Earnings Results Q2 2021 Earnings Results
07/30/2021 17:00 Earnings Calls Q2 2021 Earnings Call
05/04/2021 00:00 Earnings Results Q1 2021 Earnings Results
05/04/2021 17:00 EDT Earnings Calls Q1 2021 Earnings Call
02/11/2021 00:00 Earnings Results Q4 2020 Earnings Results
02/11/2021 17:00 EST Earnings Calls Q4 2020 Earnings Call
10/27/2020 00:00 Earnings Results Q3 2020 Earnings Results
10/27/2020 17:00 EDT Earnings Calls Q3 2020 Earnings Call
07/30/2020 17:00 EDT Earnings Calls Q2 2020 Earnings Call
07/30/2020 00:00 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Ultragenyx Pharmaceutical Inc is a US-based biopharmaceutical company. It identifies, acquires, develops, and commercialize novel products for the treatment of serious rare and ultra-rare diseases, with the focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
  • URL: https://www.ultragenyx.com
  • Investor Relations URL: https://ir.ultragenyx.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Jul. 30, 2021
  • Last Earnings Release: May. 04, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
GNOM Global X Genomics & Biotechnology ETF 4.24%
FBT First Trust NYSE Arca Biotech ETF 3.38%
KAUBX Federated Hermes Kaufmann B 2.45%
KLCKX Federated Hermes Kaufmann Large Cap R 1.85%
FKBSX Federated Hermes Kaufmann Small Cap B 1.67%
DCCRX Delaware Small Cap Core R 1.15%
FBIOX Fidelity® Select Biotechnology 0.95%
TQAAX T. Rowe Price QM US Small-Cap Gr Eq Adv 0.67%
IWO iShares Russell 2000 Growth ETF 0.53%
VTWG Vanguard Russell 2000 Growth ETF 0.53%
VTWO Vanguard Russell 2000 ETF 0.26%
IWM iShares Russell 2000 ETF 0.25%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.